JUVENTAS
Live / Applied — Third extension granted (statement of use) (as of 10 Dec 2025)
What this means for you
Not registered yet, but its 08 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97829720
- Mark type
- Stylized text
- Filed
- 08 Mar 2023
- Published for opposition
- 16 Apr 2024
- Attorney of record
- Yong Chen
Goods and services
- Class 042 — Scientific and technological services: Providing services in preparing cells product, namely, development of cells product, including chimeric antigen receptor T Cells, NK cells, DC cells, based on cells harvested from patients, for providing such cell products to hospitals, clinics or other organizations or entities involved in delivering healthcare services to patients
Owner
- JUVENTAS CELL THERAPY LTD., Beijing, CN
- JUVENTAS CELL THERAPY LTD., Beijing, CN
Prosecution history
- 10 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 3 GRANTED
- 09 Dec 2025 — SOU EXTENSION 3 FILED
- 09 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2025 — SOU EXTENSION 2 GRANTED
- 03 Jun 2025 — SOU EXTENSION 2 FILED
- 03 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Dec 2024 — SOU EXTENSION 1 GRANTED
- 08 Dec 2024 — SOU EXTENSION 1 FILED
- 07 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2024 — PUBLISHED FOR OPPOSITION
- 27 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED